Showing posts with label Vertex Pharma. Show all posts
Showing posts with label Vertex Pharma. Show all posts

Thursday, February 2, 2012

Pinnacle (PNCL) (VRTX) (JACK) (BCR) (BDX) (AIS) Ratings, Price Targets

Pinnacle Airlines Corp. (NASDAQ: PNCL), Vertex Pharmaceuticals (NASDAQ: VRTX), Jack in the Box Inc. (NASDAQ: JACK), C.R. Bard, Inc. (NYSE: BCR), Becton Dickinson (NYSE: BDX) and Antares Pharma, Inc. (NYSE: AIS) ratings and price targets.

Pinnacle Airlines Corp. (PNCL) had its “Sell” rating reiterated by Dahlman Rose. They have a price target of $0.75 on the company.

Vertex Pharmaceuticals (VRTX) had its “Hold” rating reiterated by analysts at Canaccord Genuity.

Lazard Capital initiated coverage on Jack in the Box Inc. (JACK). They placed a “Buy” rating on the company.

C.R. Bard, Inc. (BCR) had its price target raised by Jefferies Group (NYSE:JEF) from $104.00 to $104.00. They have a “Buy” rating on the company.

Becton Dickinson (BDX) was downgraded by Credit Agricole from a “Buy” rating to an “Outperform” rating.

Antares Pharma, Inc. (AIS) was upgraded by Roth Capital from a “Neutral” rating to a “Buy” rating.